Reported relationships
Latest disclosed role at each company.
| Company | Last reported as | Report date | Published |
|---|---|---|---|
| AtriCure, Inc.ATRC · Entity 2704 | Director | May 18, 2026 | May 20, 2026 |
| ClearPoint Neuro, Inc.CLPT · Entity 2367 | Director | May 21, 2026 | May 26, 2026 |
| PIPER SANDLER COMPANIESPJC · Entity 3863 | Director | December 13, 2019 | December 16, 2019 |
| ViewRay, Inc.VRAY · Entity 111118 | Director | July 21, 2023 | July 24, 2023 |
Disclosed balances
About these balances
Latest available filing per company, not a reconstructed current portfolio. Matching sequences show the last reported balance with all source rows expandable; grouping alone does not establish account ownership. Do not add unresolved positions together. Filings may omit unchanged positions, and amendments may correct only part of an older disclosure. Jointly reported shares are not necessarily this owner's personal holdings.
AtriCure, Inc.
Report date May 18, 2026 · Filed May 20, 2026
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Common StockSEC Table I · non-derivative | Direct | 55,954 |
Reported balance
After 2026-05-18 transaction · row 1
1 source rowRow 1 · 2026-05-18 · Grant · Acquired 6,144 · Balance 55,954 F1: The Reporting Person acquired these shares pursuant to a Restricted Stock Award under the AtriCure, Inc. 2023 Stock Incentive Plan. The shares will vest upon the one-year anniversary of the grant date. |
Filing footnotes · ownership attribution and instrument terms
F1: The Reporting Person acquired these shares pursuant to a Restricted Stock Award under the AtriCure, Inc. 2023 Stock Incentive Plan. The shares will vest upon the one-year anniversary of the grant date.
ClearPoint Neuro, Inc.
Report date May 21, 2026 · Filed May 26, 2026
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Restricted Stock UnitsSEC Table II · derivative / convertible security | Direct | 12,820 |
Reported balance
After 2026-05-21 transaction · row 1
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 1 · 2026-05-21 · Grant · Acquired 12,820 · Balance 12,820 F1: Each restricted stock unit represents a contingent right to receive one share of CLPT common stock. F2: The restricted stock units vest on the earlier of (i) the first anniversary of the grant date, or (ii) the day immediately preceding the Company's 2027 annual meeting of stockholders. |
Filing footnotes · ownership attribution and instrument terms
F1: Each restricted stock unit represents a contingent right to receive one share of CLPT common stock.
F2: The restricted stock units vest on the earlier of (i) the first anniversary of the grant date, or (ii) the day immediately preceding the Company's 2027 annual meeting of stockholders.
PIPER SANDLER COMPANIES
Report date December 13, 2019 · Filed December 16, 2019
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Common StockSEC Table I · non-derivative | Direct | 11,794 |
Reported balance
After 2019-12-13 transaction · row 1
1 source rowRow 1 · 2019-12-13 · Grant · Acquired 9 · Balance 11,794 F1: Dividend equivalents that are paid on shares of phantom stock are deemed reinvested in additional shares of phantom stock as of the payment date. These phantom shares accrue to the reporting person's account in the directors' deferred compensation plan. The shares of phantom stock become payable, in an equal number of shares of common stock, on the last day of the year in which the reporting person's service as a director terminates. |
| Common StockSEC Table I · non-derivative | IndirectBy IRA | 1,200 |
Reported balance
Holding disclosure · report date 2019-12-13 · row 2
Holding and transaction disclosures are not merged.
1 source rowRow 2 · Balance 1,200 |
| Common StockSEC Table I · non-derivative | IndirectBy B. Kristine Johnson Trust | 2,578 |
Reported balance
Holding disclosure · report date 2019-12-13 · row 3
Holding and transaction disclosures are not merged.
1 source rowRow 3 · Balance 2,578 |
Filing footnotes · ownership attribution and instrument terms
F1: Dividend equivalents that are paid on shares of phantom stock are deemed reinvested in additional shares of phantom stock as of the payment date. These phantom shares accrue to the reporting person's account in the directors' deferred compensation plan. The shares of phantom stock become payable, in an equal number of shares of common stock, on the last day of the year in which the reporting person's service as a director terminates.
ViewRay, Inc.
Report date July 21, 2023 · Filed July 24, 2023
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Common StockSEC Table I · non-derivative | Direct | 126,720 |
Reported balance
After 2023-07-21 transaction · row 1
1 source rowRow 1 · 2023-07-21 · Sale · Disposed 30,702 · Balance 126,720 F1: The price reported is a weighted average price. These shares were sold in multiple transactions at prices ranging from $0.051 to $0.053, inclusive. The Reporting Person undertakes to provide to the Company, any security holder of the Company, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range stated. |
Filing footnotes · ownership attribution and instrument terms
F1: The price reported is a weighted average price. These shares were sold in multiple transactions at prices ranging from $0.051 to $0.053, inclusive. The Reporting Person undertakes to provide to the Company, any security holder of the Company, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range stated.
Past disclosures · reporting ended (2)
No longer tracked through insider filings. These historical balances do not imply present ownership or a zero position.
Paragon 28, Inc.
Report date April 21, 2025 · Filed April 21, 2025
Section 16 reporting ended · disclosed 2025-04-21. Current position is not established by this disclosure.
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Common StockSEC Table I · non-derivative | Direct | 0 |
Reported balance
After 2025-04-21 transaction · row 1
1 source rowRow 1 · 2025-04-21 · Disposition to issuer · Disposed 47,347 · Balance 0 F1: In connection with the terms of an Agreement and Plan of Merger, dated January 28, 2025 (the "Merger Agreement"), by and among the Issuer, Zimmer Biomet Holdings, Inc., Zimmer, Inc. ("Parent"), and Gazelle Merger Sub I, Inc., a wholly owned subsidiary of Parent ("Merger Sub"), Merger Sub merged with and into the Issuer, with the Issuer continuing as the surviving corporation and a wholly owned subsidiary of Parent upon consummation of the merger (the "Effective Time"). F2: At the Effective Time, each outstanding share of Common Stock was automatically converted into the right to receive (i) $13.00 in cash, without interest (the "Cash Consideration") and (ii) one contractual contingent value right ("CVR") per share representing the right to receive a contingent payment of up to $1.00 in cash upon achievement of specified milestones, as specified further in the CVR Agreement, by and among Parent, Equiniti Trust Company, LLC, as rights agent, and, for certain provisions, Zimmer Biomet Holdings, Inc., as guarantor. F3: At the Effective Time, each outstanding restricted stock unit solely subject to time-based vesting conditions vested and was canceled, with the holder thereof entitled to receive, with respect to each share of Common Stock underlying such award, (x) the Cash Consideration and (y) one CVR. |
Filing footnotes · ownership attribution and instrument terms
F1: In connection with the terms of an Agreement and Plan of Merger, dated January 28, 2025 (the "Merger Agreement"), by and among the Issuer, Zimmer Biomet Holdings, Inc., Zimmer, Inc. ("Parent"), and Gazelle Merger Sub I, Inc., a wholly owned subsidiary of Parent ("Merger Sub"), Merger Sub merged with and into the Issuer, with the Issuer continuing as the surviving corporation and a wholly owned subsidiary of Parent upon consummation of the merger (the "Effective Time").
F2: At the Effective Time, each outstanding share of Common Stock was automatically converted into the right to receive (i) $13.00 in cash, without interest (the "Cash Consideration") and (ii) one contractual contingent value right ("CVR") per share representing the right to receive a contingent payment of up to $1.00 in cash upon achievement of specified milestones, as specified further in the CVR Agreement, by and among Parent, Equiniti Trust Company, LLC, as rights agent, and, for certain provisions, Zimmer Biomet Holdings, Inc., as guarantor.
F3: At the Effective Time, each outstanding restricted stock unit solely subject to time-based vesting conditions vested and was canceled, with the holder thereof entitled to receive, with respect to each share of Common Stock underlying such award, (x) the Cash Consideration and (y) one CVR.
SPECTRANETICS CORP
Report date August 09, 2017 · Filed August 11, 2017
Section 16 reporting ended · disclosed 2017-08-11. Current position is not established by this disclosure.
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| SPNC Common StockSEC Table I · non-derivative | Direct | 0 |
Reported balance
After 2017-08-09 transaction · row 1
1 source rowRow 1 · 2017-08-09 · Disposition to issuer · Disposed 31,219 · Balance 0 F1: Per the terms of the Agreement and Plan of Merger, dated as of June 27, 2017, among the Company, Philips Holding USA Inc., a Delaware corporation, and HealthTech Merger Sub, Inc., a Delaware corporation (the "Merger Agreement") and the Offer (as defined in the Merger Agreement), each share of Company common stock other than the restricted common stock described in Note 2 was validly tendered for $38.50 per share in cash, without interest and less any required withholding taxes. F2: Includes 4,780 shares of restricted common stock that, pursuant to their terms upon consummation of the Merger Agreement, were canceled at the Effective Time (as defined in the Merger Agreement) and converted into the right to receive $38.50 per share in cash, without interest. |
Filing footnotes · ownership attribution and instrument terms
F1: Per the terms of the Agreement and Plan of Merger, dated as of June 27, 2017, among the Company, Philips Holding USA Inc., a Delaware corporation, and HealthTech Merger Sub, Inc., a Delaware corporation (the "Merger Agreement") and the Offer (as defined in the Merger Agreement), each share of Company common stock other than the restricted common stock described in Note 2 was validly tendered for $38.50 per share in cash, without interest and less any required withholding taxes.
F2: Includes 4,780 shares of restricted common stock that, pursuant to their terms upon consummation of the Merger Agreement, were canceled at the Effective Time (as defined in the Merger Agreement) and converted into the right to receive $38.50 per share in cash, without interest.
Transaction history
JSON APIPurchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Company | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| December 13, 2019 Filed Dec 16, 2019 21:53 UTC | PIPER SANDLER COMPANIES PJC · Entity 3863 | GrantCommon Stock | 9 | $81.62 | $734.58 |
DisclosureSEC source: 0001230245-19-000132 · edgar.xml · nonDerivative · entry 1 JOHNSON B KRISTINE · CIK 0001231984 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 11,794 F1 · shares: Dividend equivalents that are paid on shares of phantom stock are deemed reinvested in additional shares of phantom stock as of the payment date. These phantom shares accrue to the reporting person's account in the directors' deferred compensation plan. The shares of phantom stock become payable, in an equal number of shares of common stock, on the last day of the year in which the reporting person's service as a director terminates. Read SEC document |
| November 05, 2019 Filed Nov 7, 2019 22:08 UTC | PIPER SANDLER COMPANIES PJC · Entity 3863 | GiftCommon Stock | 1,752 | $0.00 | $0.00 |
DisclosureSEC source: 0001230245-19-000112 · edgar.xml · nonDerivative · entry 3 JOHNSON B KRISTINE · CIK 0001231984 · Director 10b5-1 filing: Not disclosed Ownership: Indirect · By B. Kristine Johnson Trust Disclosed balance after: 2,578 F1 · kind: The reported transaction was a gift by the reporting person to a private foundation. Read SEC document |
| September 30, 2019 Filed Oct 1, 2019 20:10 UTC | ClearPoint Neuro, Inc. MRIC · Entity 2367 | GrantCommon Stock | 283 | $5.15 | $1,457.45 |
DisclosureSEC source: 0001534424-19-000272 · ownership.xml · nonDerivative · entry 1 JOHNSON B KRISTINE · CIK 0001231984 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 283 F1 · price: These shares were issued pursuant to the issuer's Second Amended and Restated 2013 Incentive Compensation Plan, in payment of fees owed to the reporting person under the issuer's Non-Employee Director Compensation Plan, as amended and restated. The shares were issued at a price of $5.15 per share, representing the volume-weighted average price of the issuer's common stock for the five-trading day period ended September 30, 2019. Read SEC document |
| September 13, 2019 Filed Sep 17, 2019 12:26 UTC | PIPER SANDLER COMPANIES PJC · Entity 3863 | GrantCommon Stock | 10 | $0.00 | $0.00 |
DisclosureSEC source: 0001230245-19-000083 · edgar.xml · nonDerivative · entry 1 JOHNSON B KRISTINE · CIK 0001231984 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 11,785 F1 · shares: Dividend equivalents that are paid on shares of phantom stock are deemed reinvested in additional shares of phantom stock as of the payment date. These phantom shares accrue to the reporting person's account in the directors' deferred compensation plan. The shares of phantom stock become payable, in an equal number of shares of common stock, on the last day of the year in which the reporting person's service as a director terminates. Read SEC document |
| September 01, 2019 Filed Sep 3, 2019 20:07 UTC | ClearPoint Neuro, Inc. MRIC · Entity 2367 | GrantStock Option (right to buy) · Derivative | 15,000 | $0.00 Strike: $3.92 | $0.00 |
DisclosureSEC source: 0001534424-19-000252 · ownership.xml · derivative · entry 1 JOHNSON B KRISTINE · CIK 0001231984 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 15,000 Underlying: Common Stock · 15,000 shares Expires 2029-09-01 F1 · derivative.exercise_date: The shares subject to this option vest ratably on the first, second and third anniversaries of the grant date, September 1, 2020, September 1, 2021 and September 1, 2022. Read SEC document |
| June 14, 2019 Filed Jun 17, 2019 19:43 UTC | PIPER SANDLER COMPANIES PJC · Entity 3863 | GrantCommon Stock | 10 | $73.43 | $734.30 |
DisclosureSEC source: 0001230245-19-000063 · edgar.xml · nonDerivative · entry 1 JOHNSON B KRISTINE · CIK 0001231984 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 11,775 F1 · shares: Dividend equivalents that are paid on shares of phantom stock are deemed reinvested in additional shares of phantom stock as of the payment date. These phantom shares accrue to the reporting person's account in the directors' deferred compensation plan. The shares of phantom stock become payable, in an equal number of shares of common stock, on the last day of the year in which the reporting person's service as a director terminates. Read SEC document |
| May 22, 2019 Filed May 24, 2019 12:43 UTC | AtriCure, Inc. ATRC · Entity 2704 | GrantCommon Stock | 4,208 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-19-032564 · doc4.xml · nonDerivative · entry 1 JOHNSON B KRISTINE · CIK 0001231984 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 25,670 F1 · shares: The Reporting Person acquired these shares pursuant to a Restricted Stock Award under the AtriCure, Inc. 2014 Stock Incentive Plan. The shares will vest upon the one-year anniversary of the grant date. Read SEC document |
| May 20, 2019 Filed May 20, 2019 20:25 UTC | PIPER SANDLER COMPANIES PJC · Entity 3863 | GrantCommon Stock | 1,149 | $78.36 | $90,035.64 |
DisclosureSEC source: 0001230245-19-000045 · edgar.xml · nonDerivative · entry 1 JOHNSON B KRISTINE · CIK 0001231984 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 11,765 Read SEC document |
| March 15, 2019 Filed Mar 19, 2019 19:19 UTC | PIPER SANDLER COMPANIES PJC · Entity 3863 | GrantCommon Stock | 36 | $72.63 | $2,614.68 |
DisclosureSEC source: 0001230245-19-000028 · edgar.xml · nonDerivative · entry 1 JOHNSON B KRISTINE · CIK 0001231984 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 10,616 F1 · shares: Dividend equivalents that are paid on shares of phantom stock are deemed reinvested in additional shares of phantom stock as of the payment date. These phantom shares accrue to the reporting person's account in the directors' deferred compensation plan. The shares of phantom stock become payable, in an equal number of shares of common stock, on the last day of the year in which the reporting person's service as a director terminates. Read SEC document |
| December 14, 2018 Filed Dec 18, 2018 22:01 UTC | PIPER SANDLER COMPANIES PJC · Entity 3863 | GrantCommon Stock | 11 | $66.64 | $733.04 |
DisclosureSEC source: 0001230245-18-000117 · edgar.xml · nonDerivative · entry 1 JOHNSON B KRISTINE · CIK 0001231984 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 10,580 F1 · shares: Dividend equivalents that are paid on shares of phantom stock are deemed reinvested in additional shares of phantom stock as of the payment date. These phantom shares accrue to the reporting person's account in the directors' deferred compensation plan. The shares of phantom stock become payable, in an equal number of shares of common stock, on the last day of the year in which the reporting person's service as a director terminates. Read SEC document |
| September 14, 2018 Filed Sep 18, 2018 20:04 UTC | PIPER SANDLER COMPANIES PJC · Entity 3863 | GrantCommon Stock | 9 | $77.00 | $693.00 |
DisclosureSEC source: 0001230245-18-000096 · edgar.xml · nonDerivative · entry 1 JOHNSON B KRISTINE · CIK 0001231984 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 10,569 F1 · shares: Dividend equivalents that are paid on shares of phantom stock are deemed reinvested in additional shares of phantom stock as of the payment date. These phantom shares accrue to the reporting person's account in the directors' deferred compensation plan. The shares of phantom stock become payable, in an equal number of shares of common stock, on the last day of the year in which the reporting person's service as a director terminates. Read SEC document |
| August 06, 2018 Filed Aug 7, 2018 21:10 UTC | PIPER SANDLER COMPANIES PJC · Entity 3863 | GiftCommon Stock | 1,768 | $0.00 | $0.00 |
DisclosureSEC source: 0001230245-18-000083 · edgar.xml · nonDerivative · entry 1 JOHNSON B KRISTINE · CIK 0001231984 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 10,560 F1 · kind: The reported transaction was a gift by the reporting person to a non-profit organization. Read SEC document |
| June 15, 2018 Filed Jun 18, 2018 20:06 UTC | PIPER SANDLER COMPANIES PJC · Entity 3863 | GrantCommon Stock | 9 | $80.10 | $720.90 |
DisclosureSEC source: 0001230245-18-000071 · edgar.xml · nonDerivative · entry 1 JOHNSON B KRISTINE · CIK 0001231984 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 12,328 F1 · shares: Dividend equivalents that are paid on shares of phantom stock are deemed reinvested in additional shares of phantom stock as of the payment date. These phantom shares accrue to the reporting person's account in the directors' deferred compensation plan. The shares of phantom stock become payable, in an equal number of shares of common stock, on the last day of the year in which the reporting person's service as a director terminates. Read SEC document |
| May 31, 2018 Filed Jun 1, 2018 20:30 UTC | AtriCure, Inc. ATRC · Entity 2704 | GrantCommon Stock | 5,272 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-18-034690 · doc4.xml · nonDerivative · entry 1 JOHNSON B KRISTINE · CIK 0001231984 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 21,462 F1 · shares: The Reporting Person acquired these shares pursuant to a Restricted Stock Award under the AtriCure, Inc. 2014 Stock Incentive Plan. The shares will vest upon the one-year anniversary of the grant date. Read SEC document |
| May 22, 2018 Filed May 24, 2018 20:37 UTC | AtriCure, Inc. ATRC · Entity 2704 | GrantCommon Stock | 5,221 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-18-032993 · doc4.xml · nonDerivative · entry 1 JOHNSON B KRISTINE · CIK 0001231984 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 16,190 F1 · shares: The Reporting Person acquired these shares pursuant to a Restricted Stock Award under the AtriCure, Inc. 2014 Stock Incentive Plan. The shares will vest upon the one-year anniversary of the grant date. Read SEC document |
| May 17, 2018 Filed May 18, 2018 15:33 UTC | PIPER SANDLER COMPANIES PJC · Entity 3863 | GrantCommon Stock | 1,036 | $0.00 | $0.00 |
DisclosureSEC source: 0001230245-18-000056 · edgar.xml · nonDerivative · entry 1 JOHNSON B KRISTINE · CIK 0001231984 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 12,319 Read SEC document |
| March 15, 2018 Filed Mar 16, 2018 20:30 UTC | PIPER SANDLER COMPANIES PJC · Entity 3863 | GrantCommon Stock | 42 | $86.25 | $3,622.50 |
DisclosureSEC source: 0001230245-18-000038 · edgar.xml · nonDerivative · entry 1 JOHNSON B KRISTINE · CIK 0001231984 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 11,283 F1 · shares: Dividend equivalents that are paid on shares of phantom stock are deemed reinvested in additional shares of phantom stock as of the payment date. These phantom shares accrue to the reporting person's account in the directors' deferred compensation plan. The shares of phantom stock become payable, in an equal number of shares of common stock, on the last day of the year in which the reporting person's service as a director terminates. Read SEC document |
| February 02, 2018 Filed Feb 5, 2018 21:33 UTC | PIPER SANDLER COMPANIES PJC · Entity 3863 | GiftCommon Stock | 1,558 | $0.00 | $0.00 |
DisclosureSEC source: 0001230245-18-000014 · edgar.xml · nonDerivative · entry 1 JOHNSON B KRISTINE · CIK 0001231984 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 11,241 F1 · kind: The reported transaction was a gift by the reporting person to a non-profit organization. Read SEC document |
| December 15, 2017 Filed Dec 19, 2017 17:49 UTC | PIPER SANDLER COMPANIES PJC · Entity 3863 | GrantCommon Stock | 7 | $79.10 | $553.70 |
DisclosureSEC source: 0001230245-17-000143 · edgar.xml · nonDerivative · entry 1 JOHNSON B KRISTINE · CIK 0001231984 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 12,799 F1 · shares: Dividend equivalents that are paid on shares of phantom stock are deemed reinvested in additional shares of phantom stock as of the payment date. These phantom shares accrue to the reporting person's account in the directors' deferred compensation plan. The shares of phantom stock become payable, in an equal number of shares of common stock, on the last day of the year in which the reporting person's service as a director terminates. Read SEC document |
| November 08, 2017 Filed Nov 9, 2017 20:01 UTC | AtriCure, Inc. ATRC · Entity 2704 | PurchaseCommon Stock | 1,500 | $18.36 | $27,540.00 |
DisclosureSEC source: 0001209191-17-059936 · doc4.xml · nonDerivative · entry 1 JOHNSON B KRISTINE · CIK 0001231984 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 10,969 Read SEC document |
| September 15, 2017 Filed Sep 18, 2017 20:09 UTC | PIPER SANDLER COMPANIES PJC · Entity 3863 | GrantCommon Stock | 10 | $55.10 | $551.00 |
DisclosureSEC source: 0001230245-17-000124 · edgar.xml · nonDerivative · entry 1 JOHNSON B KRISTINE · CIK 0001231984 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 12,792 F1 · shares: Dividend equivalents that are paid on shares of phantom stock are deemed reinvested in additional shares of phantom stock as of the payment date. These phantom shares accrue to the reporting person's account in the directors' deferred compensation plan. The shares of phantom stock become payable, in an equal number of shares of common stock, on the last day of the year in which the reporting person's service as a director terminates. Read SEC document |
| August 09, 2017 Filed Aug 11, 2017 14:34 UTC | SPECTRANETICS CORP SPNC · Entity 173862 | Disposition to issuerSPNC Common Stock | 31,219 | $38.50 | $1,201,931.50 |
DisclosureSEC source: 0001179110-17-011360 · edgar.xml · nonDerivative · entry 1 JOHNSON B KRISTINE · CIK 0001231984 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 F1 · shares: Per the terms of the Agreement and Plan of Merger, dated as of June 27, 2017, among the Company, Philips Holding USA Inc., a Delaware corporation, and HealthTech Merger Sub, Inc., a Delaware corporation (the "Merger Agreement") and the Offer (as defined in the Merger Agreement), each share of Company common stock other than the restricted common stock described in Note 2 was validly tendered for $38.50 per share in cash, without interest and less any required withholding taxes. F2 · shares: Includes 4,780 shares of restricted common stock that, pursuant to their terms upon consummation of the Merger Agreement, were canceled at the Effective Time (as defined in the Merger Agreement) and converted into the right to receive $38.50 per share in cash, without interest. Read SEC document |
| June 15, 2017 Filed Jun 19, 2017 14:43 UTC | PIPER SANDLER COMPANIES PJC · Entity 3863 | GrantCommon Stock | 9 | $61.80 | $556.20 |
DisclosureSEC source: 0001230245-17-000097 · edgar.xml · nonDerivative · entry 1 JOHNSON B KRISTINE · CIK 0001231984 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 12,782 F1 · shares: Dividend equivalents that are paid on shares of phantom stock are deemed reinvested in additional shares of phantom stock as of the payment date. These phantom shares accrue to the reporting person's account in the directors' deferred compensation plan. The shares of phantom stock become payable, in an equal number of shares of common stock, on the last day of the year in which the reporting person's service as a director terminates. Read SEC document |
| June 08, 2017 Filed Jun 12, 2017 17:21 UTC | SPECTRANETICS CORP SPNC · Entity 173862 | GrantSPNC Common Stock | 4,780 | $0.00 | $0.00 |
DisclosureSEC source: 0000789132-17-000092 · wf-form4_149730247960559.xml · nonDerivative · entry 1 JOHNSON B KRISTINE · CIK 0001231984 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 31,219 F1 · shares: Director compensation grant of SPNC restricted stock, vesting over 1 year, 100% vested on 6/8/2018. Read SEC document |
| May 11, 2017 Filed May 12, 2017 19:59 UTC | PIPER SANDLER COMPANIES PJC · Entity 3863 | GrantCommon Stock | 1,158 | $0.00 | $0.00 |
DisclosureSEC source: 0001230245-17-000077 · edgar.xml · nonDerivative · entry 1 JOHNSON B KRISTINE · CIK 0001231984 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 12,773 Read SEC document |
| March 21, 2017 Filed Mar 23, 2017 20:20 UTC | AtriCure, Inc. ATRC · Entity 2704 | GrantCommon Stock | 9,469 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-17-022563 · doc4.xml · nonDerivative · entry 1 JOHNSON B KRISTINE · CIK 0001231984 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 9,469 F1 · price: The Reporting Person acquired these shares pursuant to a Restricted Stock Award under the AtriCure, Inc. 2014 Stock Incentive Plan. The shares will vest 33% annually over three years from date of grant. Read SEC document |
| March 13, 2017 Filed Mar 14, 2017 20:29 UTC | PIPER SANDLER COMPANIES PJC · Entity 3863 | GrantCommon Stock | 9 | $67.80 | $610.20 |
DisclosureSEC source: 0001230245-17-000057 · edgar.xml · nonDerivative · entry 1 JOHNSON B KRISTINE · CIK 0001231984 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 11,615 F1 · shares: Dividend equivalents that are paid on shares of phantom stock are deemed reinvested in additional shares of phantom stock as of the payment date. These phantom shares accrue to the reporting person's account in the directors' deferred compensation plan. The shares of phantom stock become payable, in an equal number of shares of common stock, on the last day of the year in which the reporting person's service as a director terminates. Read SEC document |
| February 16, 2017 Filed Feb 17, 2017 21:34 UTC | PIPER SANDLER COMPANIES PJC · Entity 3863 | GiftCommon Stock | 1,100 | $0.00 | $0.00 |
DisclosureSEC source: 0001230245-17-000029 · edgar.xml · nonDerivative · entry 1 JOHNSON B KRISTINE · CIK 0001231984 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 11,606 F1 · kind: The reported transaction was a gift by the reporting person to a tax-exempt organization. Read SEC document |
| February 16, 2017 Filed Feb 5, 2018 21:36 UTC Amendment | PIPER SANDLER COMPANIES PJC · Entity 3863 | GiftCommon Stock | 1,100 | $0.00 | $0.00 |
DisclosureSEC source: 0001230245-18-000015 · edgar.xml · nonDerivative · entry 1 JOHNSON B KRISTINE · CIK 0001231984 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 11,606 F1 · date: This amendment is being filed to correctly reflect the disposition of securities rather than the acquisition of securities as was previously reported. F2 · kind: The reported transaction was a gift by the reporting person to a tax-exempt organization. Read SEC document |
| November 04, 2016 Filed Nov 4, 2016 20:30 UTC | PIPER SANDLER COMPANIES PJC · Entity 3863 | SaleCommon Stock | 1,425 | $53.45 | $76,162.40 |
DisclosureSEC source: 0001230245-16-000314 · edgar.xml · nonDerivative · entry 1 JOHNSON B KRISTINE · CIK 0001231984 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 12,706 Read SEC document |
| November 04, 2016 Filed Dec 1, 2016 21:40 UTC Amendment | PIPER SANDLER COMPANIES PJC · Entity 3863 | SaleCommon Stock | 1,425 | $53.45 | $76,162.40 |
DisclosureSEC source: 0001230245-16-000327 · edgar.xml · nonDerivative · entry 1 JOHNSON B KRISTINE · CIK 0001231984 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 12,706 F1 · date: This amendment is being filed to correctly reflect the disposition of securities rather than the acquisition of securities as was previously reported. Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.